• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年轻受试者、老年受试者和百岁老人的爱泼斯坦-巴尔病毒永生化B淋巴细胞中的氧化DNA损伤修复及PARP 1和PARP 2表达

Oxidative DNA damage repair and parp 1 and parp 2 expression in Epstein-Barr virus-immortalized B lymphocyte cells from young subjects, old subjects, and centenarians.

作者信息

Chevanne Marta, Calia Corinne, Zampieri Michele, Cecchinelli Barbara, Caldini Riccardo, Monti Daniela, Bucci Laura, Franceschi Claudio, Caiafa Paola

机构信息

Department of Experimental Pathology and Oncology, University of Florence, Italy.

出版信息

Rejuvenation Res. 2007 Jun;10(2):191-204. doi: 10.1089/rej.2006.0514.

DOI:10.1089/rej.2006.0514
PMID:17518695
Abstract

Oxidative DNA damage has been implicated in the aging process and in some of its features such as telomere shortening and replicative senescence. Poly(ADP-ribosyl)ation is involved in many molecular and cellular processes, including DNA damage detection and repair, chromatin modification, transcription, and cell death pathways. We decided to examine the behavior of poly(ADP-ribosyl)ation in centenarians, i.e., those subjects who represent the best example of longevity having reached a very advanced age avoiding the main age-associated diseases. In this study we investigated the relationship between DNA repair capacity and poly(ADP-ribose) polymerase activity in Epstein-Barr virus-immortalized B lymphocyte cell lines from subjects of three different groups of age, including centenarians. Our data show that cells from centenarians have characteristics typical of cells from young people both in their capability of priming the mechanism of repair after H(2)O(2) sublethal oxidative damage and in poly(ADP-ribosyl)ation capacity, while in cells from old subjects these phenomena are delayed or decreased. Moreover, cells from old subjects show a constitutive expression level of both parp 1 and parp 2 genes reduced by a half, together with a reduced presence of modified PARP 1 and other poly(ADP-ribosyl)ated chromatin proteins in comparison to cells from young subjects and centenarians. Our data support the hypothesis that this epigenetic modification is an important regulator of the aging process in humans and it appears to be rather preserved in healthy centenarians, the best example of successful aging.

摘要

氧化性DNA损伤与衰老过程及其某些特征有关,如端粒缩短和复制性衰老。聚(ADP - 核糖)化参与许多分子和细胞过程,包括DNA损伤检测与修复、染色质修饰、转录和细胞死亡途径。我们决定研究百岁老人(即那些代表长寿最佳范例、年事已高却避免了主要年龄相关疾病的个体)体内聚(ADP - 核糖)化的表现。在本研究中,我们调查了来自三个不同年龄组(包括百岁老人)的受试者的爱泼斯坦 - 巴尔病毒永生化B淋巴细胞系中DNA修复能力与聚(ADP - 核糖)聚合酶活性之间的关系。我们的数据表明,百岁老人的细胞在H₂O₂亚致死性氧化损伤后启动修复机制的能力以及聚(ADP - 核糖)化能力方面具有年轻人细胞的典型特征,而老年受试者的细胞中这些现象则延迟或减弱。此外,与年轻受试者和百岁老人的细胞相比,老年受试者的细胞中parp 1和parp 2基因的组成型表达水平降低了一半,同时修饰的PARP 1和其他聚(ADP - 核糖)化染色质蛋白的含量也减少。我们的数据支持这样一种假设,即这种表观遗传修饰是人类衰老过程的重要调节因子,并且在健康的百岁老人(成功衰老的最佳范例)中似乎得到了较好的保留。

相似文献

1
Oxidative DNA damage repair and parp 1 and parp 2 expression in Epstein-Barr virus-immortalized B lymphocyte cells from young subjects, old subjects, and centenarians.年轻受试者、老年受试者和百岁老人的爱泼斯坦-巴尔病毒永生化B淋巴细胞中的氧化DNA损伤修复及PARP 1和PARP 2表达
Rejuvenation Res. 2007 Jun;10(2):191-204. doi: 10.1089/rej.2006.0514.
2
Increased poly(ADP-ribose) polymerase activity in lymphoblastoid cell lines from centenarians.百岁老人淋巴母细胞系中聚(ADP - 核糖)聚合酶活性增加。
J Mol Med (Berl). 1998 Apr;76(5):346-54. doi: 10.1007/s001090050226.
3
New polymorphisms in the human poly(ADP-ribose) polymerase-1 coding sequence: lack of association with longevity or with increased cellular poly(ADP-ribosyl)ation capacity.人类聚(ADP - 核糖)聚合酶 -1编码序列中的新多态性:与长寿或细胞聚(ADP - 核糖基)化能力增加无关。
J Mol Med (Berl). 2000;78(8):431-40. doi: 10.1007/s001090000132.
4
Poly(ADP-ribosyl)ation: a posttranslational protein modification linked with genome protection and mammalian longevity.聚(ADP - 核糖基)化:一种与基因组保护和哺乳动物寿命相关的翻译后蛋白质修饰。
Biogerontology. 2000;1(1):41-6. doi: 10.1023/a:1010089924898.
5
Poly(ADP-ribose) polymerase-1 activation during DNA damage and repair.DNA损伤与修复过程中聚(ADP-核糖)聚合酶-1的激活
Methods Enzymol. 2006;409:493-510. doi: 10.1016/S0076-6879(05)09029-4.
6
Poly(ADP-ribosyl)ation and aging.聚(ADP - 核糖基)化与衰老
Exp Gerontol. 2004 Nov-Dec;39(11-12):1599-601. doi: 10.1016/j.exger.2004.07.010.
7
Poly(ADP-ribose) polymerase-1 is a nuclear epigenetic regulator of mitochondrial DNA repair and transcription.聚(ADP-核糖)聚合酶 1 是一种核内表观遗传调节因子,可调节线粒体 DNA 修复和转录。
Mol Pharmacol. 2011 Jun;79(6):932-40. doi: 10.1124/mol.110.070110. Epub 2011 Mar 11.
8
The emerging role of poly(ADP-ribose) polymerase-1 in longevity.聚(ADP - 核糖)聚合酶 -1在长寿中的新作用。
Int J Biochem Cell Biol. 2005 May;37(5):1043-53. doi: 10.1016/j.biocel.2004.10.006. Epub 2004 Dec 15.
9
Poly(ADP-ribosyl)ation, PARP, and aging.聚(ADP-核糖)化、PARP与衰老
Sci Aging Knowledge Environ. 2004 Dec 8;2004(49):re9. doi: 10.1126/sageke.2004.49.re9.
10
New perspectives on the plant PARP family: Arabidopsis PARP3 is inactive, and PARP1 exhibits predominant poly (ADP-ribose) polymerase activity in response to DNA damage.植物 PARP 家族的新视角:拟南芥 PARP3 无活性,而 PARP1 在响应 DNA 损伤时表现出主要的多聚(ADP-核糖)聚合酶活性。
BMC Plant Biol. 2019 Aug 19;19(1):364. doi: 10.1186/s12870-019-1958-9.

引用本文的文献

1
The PARP inhibitor olaparib promotes senescence in murine macrophages.聚(ADP-核糖)聚合酶(PARP)抑制剂奥拉帕利可促进小鼠巨噬细胞衰老。
Geroscience. 2025 May 6. doi: 10.1007/s11357-025-01679-6.
2
Maximum lifespan and brain size in mammals are associated with gene family size expansion related to immune system functions.哺乳动物的最大寿命和脑容量与免疫系统功能相关的基因家族大小扩展有关。
Sci Rep. 2025 Apr 29;15(1):15087. doi: 10.1038/s41598-025-98786-3.
3
Factors involved in human healthy aging: insights from longevity individuals.人类健康衰老涉及的因素:来自长寿者的见解。
Front Med. 2025 Apr;19(2):226-249. doi: 10.1007/s11684-024-1120-4. Epub 2025 Mar 22.
4
Mitochondrion quality control for longevity promotion.促进长寿的线粒体质量控制。
Metabol Open. 2023 Oct 21;22:100259. doi: 10.1016/j.metop.2023.100259. eCollection 2024 Jun.
5
Specific and shared biological functions of PARP2 - is PARP2 really a lil' brother of PARP1?PARP2的特异性和共享生物学功能——PARP2真的是PARP1的“小弟”吗?
Expert Rev Mol Med. 2024 May 3;26:e13. doi: 10.1017/erm.2024.14.
6
Muscle PARP1 inhibition extends lifespan through AMPKα PARylation and activation in .肌肉 PARP1 抑制通过 AMPKα 的 PAR 化和激活延长寿命。
Proc Natl Acad Sci U S A. 2023 Mar 28;120(13):e2213857120. doi: 10.1073/pnas.2213857120. Epub 2023 Mar 22.
7
Longevity, Centenarians and Modified Cellular Proteodynamics.长寿、百岁老人和改良的细胞蛋白质动态学。
Int J Mol Sci. 2023 Feb 2;24(3):2888. doi: 10.3390/ijms24032888.
8
PARP1 and OGG1 in Medicated Patients With Depression and the Response to ECT.PARP1 和 OGG1 在接受药物治疗的抑郁症患者中的表达与对 ECT 的反应。
Int J Neuropsychopharmacol. 2023 Feb 14;26(2):107-115. doi: 10.1093/ijnp/pyac078.
9
PARP1 inhibition enhances reactive oxygen species on gut microbiota.PARP1 抑制剂增强肠道微生物组的活性氧。
J Cell Physiol. 2022 Nov;237(11):4169-4179. doi: 10.1002/jcp.30861. Epub 2022 Aug 22.
10
Skeletal Aging and Osteoporosis: Mechanisms and Therapeutics.骨骼衰老与骨质疏松症:机制与治疗。
Int J Mol Sci. 2021 Mar 29;22(7):3553. doi: 10.3390/ijms22073553.